High-dose etoposide could discriminate the benefit from autologous peripheral blood stem cell transplantation in the patients with refractory diffuse large B cell lymphoma

To evaluate the strategy of using high-dose etoposide mobilization followed by autologous peripheral blood stem cell transplantation (APBSCT) in patients with diffuse large B cell lymphoma (DLBCL) refractory to rituximab-based chemotherapy. Forty patients with refractory DLBCL were treated with high...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Yu, Wan, Liping, Yang, Juan, Zhu, Jun, Jiang, Jieling, Li, Su, Song, Xianmin, Wang, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423309/
https://www.ncbi.nlm.nih.gov/pubmed/30715566
http://dx.doi.org/10.1007/s00277-019-03605-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423309/
https://www.ncbi.nlm.nih.gov/pubmed/30715566
http://dx.doi.org/10.1007/s00277-019-03605-1

Ejemplares similares